USPTO 2015–2025 USPTO PatentsView US Corporation

Boston Scientific Scimed, Inc.

USPTO PatentsView assignee record - 3,361 granted patents across 128 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Boston ranks #108 of 49,997 tracked US assignees by granted-patent volume, with 3,361 patents across 128 technology areas.

#108
of 49,997 US assignees by volume
Top 1%
by Innovation Score (70.3/100)
16.8
avg claims per patent
+6%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R108 · US Corporation #108 · 3,361 grants

GRANTS-LARGE · TOP-DECILE · NEAR-PEER · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-LARGE 3.4K grants
  • TOP-DECILE #108/49,997
  • NEAR-PEER Snap
  • CPC-WIDE A61B · 128 areas
  • INNOV-STRONG 70.3/100
  • CLAIMS-RICH 16.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +6% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Snap Inc. (±16 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Boston

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Boston's Innovation Score is 70.3/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Boston's grant cadence moved

Between 2020–2024, Boston Scientific Scimed, Inc. received 1,568 grants versus 1,480 in 2015–2019 (+6% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2024 at 388 grants and bottomed in 2015 at 251. Lead class A61B accounts for 70.3% of the portfolio across 128 subclasses. Volume neighbours: Corning Incorporated (#104) and Toshiba TEC Kabushiki Kaisha (#112).

Boston's three-year grant acceleration

From 2019–2021 to 2022–2024, Boston Scientific Scimed, Inc. moved from 910 to 969 grants (1.06x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,025. See the growth leaderboard.

Who files at Boston's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Boston holds 3,361 patents at rank #108, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Boston

By rank, the assignees closest to #108 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Boston's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Boston, neither rank-band nor same-CPC leaders (those blocks stay above).

Boston's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

70 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

200250300350400 20152016201720182019202020212022202320242025 313
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Boston Scientific Scimed, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 251 7.5%
2016 313 9.3%
2017 322 9.6%
2018 283 8.4%
2019 311 9.3%
2020 330 9.8%
2021 269 8.0%
2022 287 8.5%
2023 294 8.7%
2024 388 11.5%
2025partial year 313 9.3%

Which technologies does Boston Scientific Scimed, Inc. patent most?

Top 15 of 128 technology areas

Where it ranks

Overall rank by patents

#108

of 49,997 tracked assignees

Innovation Score

70.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Boston Scientific Scimed, Inc.'s patent record in context - here's where to go next.

  • Boston Scientific Scimed, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 70.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #108 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Boston Scientific Scimed, Inc. against Corning Incorporated, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 70.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.